Trials / No Longer Available
No Longer AvailableNCT03439475
AMG 714 Expanded Access Program
- Status
- No Longer Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Amgen · Industry
- Sex
- —
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Expanded access requests for AMG 714 may be considered for adult patients with biopsy proven Refractory Celiac Disease Type II who have failed all available treatment options and do not have EATL. To request access, use Responsible Party contact information provided in this record.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | AMG 714 |
Timeline
- First posted
- 2018-02-20
- Last updated
- 2025-05-04
Source: ClinicalTrials.gov record NCT03439475. Inclusion in this directory is not an endorsement.